Making the Most of 4%
Pediatric cancer research receives just 4% of the federally-funded annual budget from the National Cancer Institute (NCI). Much of this is do the high cure rate of pediatric cancers when compared to cancers in other populations. While the cure rate for pediatric cancer may be comparatively high, the childhood cancer community still relies on support beyond this 4% to provide the necessary research and clinical trials for patients of the rarest cancer diagnoses.
We’ve come a long way with the 4% of funds allocated by the NCI; but we still have a long way to go to provide the future each child effected by pediatric cancer deserves. Imagine what we could do with your help.
"The field has proven that research cures cancer. So we can’t rest until we cure everyone."-Dr. Timothy Cripe MD, PhD, Chief of the Division of Hematology, Oncology and Blood and Marrow Transplant
Research: from Bench to Bedside
Improving the Quality of Life for Patients
While the survival rate of pediatric cancer has improved greatly in the last 30 years, there are still many long lasting side effects of the treatment that stay with the survivor well after a cure diagnosis. Depending on which part of the body is being treated and how, a long and diverse list of complications still follow pediatric cancer survivors.
Our survivorship Clinics strive to improve the quality of all aspects of life – medical, emotional, educational, and social of the children as they grow into adulthood. Learn more about our clinics.
Inside Survivorship Clinic with Dr. Randal Olshefski
Cancer survivorship is a journey that doesn’t end after treatment. The effects of the disease and treatments can be felt for decades. Dr. Randal Olshefski team team makes sure childhood cancer survivors at Nationwide Children’s have specialized care that is tailored to their survivorship needs.
Battle on Baby Boy!
Meet Nathan, a three-year-old both with LiFraumeni Syndrome. Now over one year strong from his diagnosis, learn more about his journey to recovery.
Going Gold to Crush Cancer
Helping Patients on a Global Scale
At Nationwide Children’s, we’re on the cutting edge of solutions for pediatric cancer patients worldwide. Our Hematology, Oncology and Blood and Marrow Transplant teams are leading collaborations to investigate innovative treatments for cancer.
The NEXT Consortium
The NEXT Consortium is a collaborative research model that unites multiple research centers with the goal of expediting the most advanced treatments in the shortest timeframe possible in pediatric cancers.
Nationwide Children’s is a leader in virotherapy research, including participating in the first clinical trial of virotherapy in pediatric cancers.
Good Manufacturing Practice
Nationwide Children’s is one of the first pediatric institutions in the country to build a Good Manufacturing Practice facility designed to research the rarest pediatric cancers. The space ensures the highest level of product safety and purity to support more accurate early phase clinical trials.
Inside Dr. Cripe’s Lab
A new child is diagnosed with cancer in the United States every 35 minutes. That means during your lunch break, two families were devastated. Dr. Cripe is determined to make a difference for those families, starting in his research lab.
Has the Cure for Cancer Been Within Us All Along?
By learning to manipulate the immune system to target cancer cells, clinician-scientists are ushering in a new era in cancer treatments.
Invisibility cloaks, magic beans and fighting cancer. Learn how Dr. Cripe is tricking the body into thinking cancer is an infection.